Congenital Heart Surgery in Children — Cost, Top Hospitals & Success Rates | MyMedicPlus

Congenital heart surgery encompasses the surgical correction or palliation of structural abnormalities of the heart and great vessels that are present from birth. Congenital heart disease (CHD) is the most common birth defect, affecting approximately 8–9 per 1,000 live births (approximately 1.35 million babies worldwide annually). Defects range from simple, haemodynamically insignificant anomalies (small muscular ventricular septal defects that close spontaneously) to complex, life-threatening lesions requiring surgical intervention in the first days of life (hypoplastic left heart syndrome, transposition of the great arteries). Surgery is performed by paediatric cardiac surgeons using cardiopulmonary bypass (heart-lung machine) — a system that temporarily takes over the function of the heart and lungs during surgery, enabling the surgeon to operate on a still, bloodless heart. Deep hypothermic circulatory arrest (cooling the body to 18–22°C and temporarily stopping blood flow) is used for arch reconstruction in neonates. Minimally invasive congenital heart surgery through smaller incisions or robotic-assisted techniques is available at selected advanced centres for ASD closure, VSD repair, and pulmonary valve procedures. Catheter-based interventions (cardiac catheterisation) — including device closure of ASDs and PDAs, balloon valvotomy, and stent implantation — are increasingly used as primary treatment or as bridge to surgery for selected defects.

The most commonly surgically treated congenital heart defects include: ventricular septal defect (VSD) — the most common CHD, a hole between the lower chambers of the heart, repaired with a patch when haemodynamically significant; atrial septal defect (ASD) — a hole between the upper chambers, treated by surgical or catheter-based device closure; patent ductus arteriosus (PDA) — a persistent foetal blood vessel between the aorta and pulmonary artery, treated by surgical ligation or catheter-based coil/device closure; tetralogy of Fallot (TOF) — a combination of four defects (VSD, pulmonary stenosis, right ventricular hypertrophy, overriding aorta) repaired in one operation at 3–6 months; transposition of the great arteries (TGA) — the aorta and pulmonary artery arise from the wrong ventricles, corrected by the arterial switch operation (ASO) in the first 2 weeks of life; coarctation of the aorta — narrowing of the main body artery, repaired by resection and end-to-end anastomosis or subclavian flap technique; hypoplastic left heart syndrome (HLHS) — underdevelopment of the left heart, requiring three-stage palliative reconstruction (Norwood, Glenn, Fontan procedures); and pulmonary atresia, truncus arteriosus, and total anomalous pulmonary venous connection (TAPVC), each requiring specific surgical approaches.

Surgical intervention is determined by the haemodynamic significance of the defect, the child's symptoms, and the risk of long-term complications if left uncorrected. Neonatal emergencies (TGA, total anomalous pulmonary venous connection with obstruction, critical pulmonary stenosis) require surgery within days of birth after prostaglandin E1 stabilisation. Simple defects (moderate VSDs, moderate ASDs) are corrected electively at 3–12 months before pulmonary vascular disease develops. Complex defects (TOF, truncus arteriosus) are corrected at 3–6 months. Palliative procedures may be performed in the neonatal period as a bridge to definitive repair. Pre-operative evaluation includes foetal echocardiography (for prenatally diagnosed CHD), transthoracic echocardiography (the primary diagnostic tool), cardiac catheterisation for haemodynamic assessment and pulmonary vascular resistance measurement, cardiac MRI or CT for complex anatomy, genetics consultation (chromosomal abnormalities such as Down syndrome, DiGeorge syndrome, or Turner syndrome affect 20–30% of CHD patients), and neonatal metabolic and physiological stabilisation. Surgical timing is individualised by the cardiac team, aiming to correct before irreversible pulmonary hypertension (Eisenmenger syndrome) develops — which renders surgical repair impossible.

Advances in paediatric cardiac surgery, perfusion technology, and post-operative ICU care have dramatically improved outcomes over the past 30 years. Simple defect repair (VSD, ASD closure) carries operative mortality under 1%. Tetralogy of Fallot repair has operative mortality of 1–2% at experienced centres with 30-year survival exceeding 85%. Arterial switch operation for TGA has mortality of 2–4% at high-volume centres and provides biventricular correction, with 20-year survival of 88–90% in recent series. Norwood procedure for HLHS (the most complex operation in all of surgery) has improved from 25% operative mortality in the 1980s to 5–15% at expert centres today, with 5-year survival of 60–70% after all three palliation stages. Catheter-based device closure of ASDs (Amplatzer Occluder) is now the standard of care for secundum ASDs, eliminating the need for open surgery in suitable cases. Children who undergo successful CHD repair achieve normal or near-normal quality of life, physical activity, school performance, and long-term survival in the majority of cases, particularly for simple defects.

Congenital heart surgery carries risks proportional to defect complexity and patient physiological status. Simple defect repairs (VSD, ASD) carry operative mortality under 1% and major complication rates of 3–5%. Complex neonatal surgery (Norwood, TGA switch) carries mortality of 5–15% at experienced centres. Low cardiac output syndrome — impaired heart function immediately after bypass — is the most common post-operative complication (10–20%), managed with inotropes and mechanical support if necessary. Complete heart block requiring permanent pacemaker implantation occurs in 1–3% of cases due to injury to the cardiac conduction system near the AV node or Bundle of His. Residual defects (incomplete VSD closure, residual pulmonary stenosis) may require catheter or surgical re-intervention. Chylothorax (lymphatic leakage into the chest cavity) complicates 1–5% of operations. Stroke and neurological injury from cardiopulmonary bypass or low perfusion affects 5–10% (subclinical neurodevelopmental impairment is more common than overt stroke). Post-operative infections including sternal wound infection and endocarditis are managed aggressively. Long-term complications include right ventricular dysfunction after TOF repair, pulmonary regurgitation requiring pulmonary valve replacement in adulthood, and residual haemodynamic abnormalities requiring lifelong cardiological follow-up.

India is one of the world's leading destinations for affordable high-quality congenital heart surgery. Simple CHD repair (VSD, ASD) costs USD 3,500–8,000 at leading cardiac centres (Narayana Hrudayalaya Bangalore, AIIMS Delhi, Apollo Chennai, Fortis Escorts New Delhi, Amrita Medical Centre Kochi), inclusive of surgery, cardiopulmonary bypass, ICU, and 7–10 days hospitalisation. Complex CHD surgery (TOF repair, arterial switch) costs USD 6,000–14,000. Multi-stage palliative procedures for HLHS or complex cyanotic CHD cost USD 8,000–18,000 per stage. Narayana Hrudayalaya, founded by Dr Devi Shetty, is internationally recognised for performing the largest volume of paediatric cardiac operations globally at radically subsidised costs. In Thailand, paediatric cardiac surgery costs USD 12,000–25,000; Singapore USD 20,000–50,000; Turkey USD 8,000–20,000. In the USA, VSD repair costs USD 50,000–120,000; complex CHD surgery USD 100,000–400,000. The savings in India can be 70–90% compared to the USA, making India a first choice for international paediatric cardiac surgery patients from over 50 countries.

Congenital heart surgery encompasses open surgical repair, catheter-based procedures, and staged palliation dependent on defect anatomy:

• Open repair with cardiopulmonary bypass (CPB): Arterial and venous cannulae divert blood through the heart-lung machine; the heart is arrested with cold cardioplegia solution. Standard for intracardiac repairs including VSD patch closure, TOF complete repair (right ventricular outflow reconstruction + VSD patch), atrial septal defect repair, and atrioventricular septal defect repair. Deep hypothermic circulatory arrest (DHCA at 18–22°C) enables aortic arch reconstruction in neonates (Norwood, interrupted aortic arch repair) by stopping circulation temporarily to provide a bloodless operating field.
• Arterial switch operation (ASO) for TGA: The great vessels are transected above the semilunar valves, coronary arteries are reimplanted into the neopulmonary root, and the vessels crossed and reanastomosed to the correct ventricles. Must be performed before left ventricular regression (within 2 weeks of birth). Technically demanding; operative mortality 2–5% at expert centres.
• Single-ventricle palliation (HLHS and functional single ventricle): Stage 1 Norwood (Sano variant): Damus-Kaye-Stansel anastomosis + right ventricle-pulmonary artery conduit. Stage 2 Bidirectional Glenn: superior vena cava to pulmonary artery anastomosis at 4–6 months. Stage 3 Fontan completion: inferior vena cava to pulmonary artery baffle at 2–4 years, creating total cavopulmonary circulation.
• Catheter-based interventions: Transcatheter device closure of secundum ASD (Amplatzer Septal Occluder) and PDA (coil, Amplatzer Duct Occluder) eliminates open surgery in suitable anatomy. Balloon pulmonary valvotomy for critical pulmonary stenosis in neonates; balloon aortic valvotomy as bridge to surgery; stent implantation in ductal-dependent arch lesions or branch pulmonary artery stenosis.
• Hybrid procedures: Bilateral PA banding plus ductal stenting via surgical exposure without CPB as a Stage 1 alternative for HLHS in highest-risk neonates, or in centres building cardiac surgery capacity.

All children who undergo congenital heart surgery require lifelong cardiology follow-up — the complexity and frequency depend on the defect severity and repair type:

• PCICU phase (1–14 days): Invasive haemodynamic monitoring; mechanical ventilation until haemodynamically stable and adequate gas exchange; inotropic support (dopamine, milrinone, adrenaline). Surveillance for low cardiac output syndrome (common 6–18 hours post-bypass), arrhythmias (particularly junctional ectopic tachycardia after atrioventricular repairs), chylothorax (1–5%), and vocal cord palsy after arch surgery.
• Discharge echocardiogram: Confirms repair integrity, residual shunts, ventricular function, and valve competence before discharge.
• Outpatient cardiology (3-monthly first year, then 6-monthly to annual): Transthoracic echocardiography; ECG and Holter monitoring for arrhythmias (particularly post-TOF repair — RBBB universal; sustained VT risk increases with age); exercise testing from school age; endocarditis prophylaxis education.
• Transition to Adult Congenital Heart Disease (ACHD) service at 16–18 years: Essential for all repaired CHD patients. Adult issues include pulmonary valve regurgitation after TOF repair (requiring transcatheter or surgical pulmonary valve replacement), Fontan circulation late complications (protein-losing enteropathy, Fontan failure), and reproductive counselling.

Surgery or catheter-based repair is the only definitive treatment for haemodynamically significant CHD. Alternatives are limited:

• Catheter-based intervention instead of surgery: For ASD, PDA, pulmonary stenosis, and selected coarctation, catheter-based intervention is the preferred approach — less invasive, shorter recovery, no sternotomy. This is an alternative to open surgery, not to treatment itself.
• Medical management alone: Effective only as temporisation or for specific lesions. Prostaglandin E1 maintains ductal patency as a bridge to surgery. Diuretics and ACE inhibitors manage heart failure in VSD awaiting repair. Indomethacin closes PDA medically in preterm neonates (not in term newborns). None are curative for structural defects.
• Watchful waiting (minor defects only): Small muscular VSDs (<3 mm) close spontaneously in 80–90% by age 2. Trivial secundum ASDs (<5 mm) may be observed. Mildly elevated right ventricular pressure from mild pulmonary stenosis (gradient <40 mmHg) can be observed without intervention. All require serial echocardiographic surveillance.
• Cardiac transplantation: For unrepairable complex anatomy or failed palliation — Fontan failure, severe heterotaxy beyond conventional repair. Paediatric heart transplantation achieves 50% 15-year survival at expert centres; limited by donor availability.